When treated in a hyperbaric chamber such as those used in our center, these are the indications which meet the selection criteria to qualify for reimbursement under current CMS guidelines. Usually these guidelines are also followed by commercial carriers. The list below identifies those indications we currently treat in our center:
Diabetic wounds of the lower extremities in patients who meet the following three criteria:
- Patient has type I or type II diabetes and has a lower extremity wound that is due to diabetes.
- Patient has a wound classified as Wagner Grade III or higher; and
- Patient has failed an adequate course of standard wound therapy
The use of HBO therapy will be covered as adjunctive therapy only after there are no measurable signs of healing for at least 30 days of treatment with standard wound therapy, and must be used in addition to standard wound care.
Chronic Refractory Osteomyelitis as an adjunct to conventional medical and surgical management
Preservation of compromised skin grafts or flaps. This indication is not for primary management of wounds, and excludes artificial skin grafts.
Soft tissue radionecrosis (Late Effects of Radiation) as an adjunct to conventional treatment, including radiation proctitis, cystitis, and enteritis
Osteoradionecrosis as an adjunct to conventional management
Actinomycosis, only as an adjunct to conventional therapy when the disease process is refractory to antibiotics and surgical treatment
Inpatient Program -- Under Development
Inpatient program is in development. The list below identifies those indications we will treat when inpatient program is established, as well as the indications listed above:
Acute carbon monoxide intoxication
Progressive necrotizing infections (necrotizing fasciitis, Meleney’s ulcer)
Crush injuries and suturing of severed limbs. HBO therapy is a valuable adjunctive therapy when loss of function, limb, or life is threatened.
Acute traumatic peripheral ischemia. HBO therapy is a valuable adjunctive treatment to be used in combination with accepted standard therapeutic measures when loss of function, limb, or life is threatened
Acute peripheral arterial insufficiency